Propofol-related infusion syndrome (PRIS) is a lethal condition characterized by multiple organ system failures. It can occur due to prolonged administration of propofol (an anesthetic) in mechanically …

Propofol-related Infusion Syndrome (PRIS) is a life-threatening condition characterised by acute refractory bradycardia progressing to asystole and one or more of:

Propofol infusion syndrome (PRIS) is a rare syndrome which affects patients undergoing long-term treatment with high doses of the anaesthetic and sedative drug propofol.

Mechanism of PRIS High doses of propofol (greater than 3mg/kg/h) lead to direct inhibition and uncoupling of mitochondrial electron transport chains, leading to greater reliance on anaerobic …

3 days ago · The Power Reactor Information System (PRIS), developed and maintained by the IAEA for over five decades, is a comprehensive database focusing on nuclear power plants worldwide.

Feb 5, 2024 · Aside from propofol dose, other risk factors for PRIS include critical illness, use of vasopressors and steroids, starvation or malnutrition, and subclinical mitochondrial disease.

Apr 30, 2024 · Propofol-related infusion syndrome (PRIS) is a rare but severe condition associated with the administration of propofol, an anesthetic commonly used for sedation in medical procedures. …

Oct 27, 2025 · PRIS is a rare but serious, and often fatal, adverse reaction linked to the continuous, high-dose administration of the sedative medication propofol. It was initially observed in pediatric …

The term PRIS—propofol infusion syndrome—was originally coined by Bray in 1998 to describe the adverse effects associated with the use of propofol in the paediatric population.

If PRIS is suspected, propofol should be discontinued and an alterna-tive sedative agent initiated. General measures to support cardiac and renal function should be initiated promptly in patients with …